Junshi Biosciences(688180.SH)

Last Updated 00:00:00
longbridge loading

Hong Kong Biotech Stocks Decline Amid Market Volatility

CoinLive·
HK
09995
+1.06%
HK
01877
+2.48%
SH
688180
+2.26%
CoinLive·
HK
09995
+1.06%
HK
01877
+2.48%
SH
688180
+2.26%

Junshi Biosciences Board Approves 2026 Q1 Report at Fully Attended Meeting

Tip Ranks·
HK
01877
+2.48%
SH
688180
+2.26%
Tip Ranks·
HK
01877
+2.48%
SH
688180
+2.26%

Junshi Biosciences Shareholder Plans Up to 2% Stake Reduction

Tip Ranks·
SH
688180
+2.26%
HK
01877
+2.48%
SZ
159837
-0.22%
Tip Ranks·
SH
688180
+2.26%
HK
01877
+2.48%
SZ
159837
-0.22%

02:47 ET2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations

prnewswire·
SH
688180
+2.26%
HK
01877
+2.48%
US
FBT
+0.54%
prnewswire·
SH
688180
+2.26%
HK
01877
+2.48%
US
FBT
+0.54%

Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%

Wallstreetcn·
SZ
159892
-0.71%
SH
516820
-0.60%
SZ
159849
-0.21%
Wallstreetcn·
SZ
159892
-0.71%
SH
516820
-0.60%
SZ
159849
-0.21%

Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase

Tip Ranks·
SH
512290
-0.11%
SZ
159615
-0.30%
SH
516930
-0.64%
Tip Ranks·
SH
512290
-0.11%
SZ
159615
-0.30%
SH
516930
-0.64%

Strong Growth in Innovative Drug Revenue, Biopharmaceutical Companies' Performance Shows High "Innovation" Content

Wallstreetcn·
SH
588250
+0.28%
SZ
159992
+0.13%
SH
688331
+3.73%
Wallstreetcn·
SH
588250
+0.28%
SZ
159992
+0.13%
SH
688331
+3.73%

Shanghai Junshi Biosciences Schedules 2025 Results Briefing for Investor Q&A

Tip Ranks·
SH
688180
+2.26%
HK
01877
+2.48%
Tip Ranks·
SH
688180
+2.26%
HK
01877
+2.48%

Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit

Wallstreetcn·
SH
688336
-1.44%
SH
688513
-0.07%
HK
01877
+2.48%
Wallstreetcn·
SH
688336
-1.44%
SH
688513
-0.07%
HK
01877
+2.48%

Shanghai Junshi Biosciences SEHK 1877 Valuation After Mixed Recent Share Performance And DCF Upside Potential

Simplywall·
SH
688180
+2.26%
HK
01877
+2.48%
SH
513700
-0.53%
Simplywall·
SH
688180
+2.26%
HK
01877
+2.48%
SH
513700
-0.53%
© 2026 Longbridge｜Disclaimer